{
    "2019-09-04": [
        [
            {
                "time": "2023-10-15",
                "original_text": "Lessons From AbbVie's $5.8 Billion Blunder With Cancer Drug Rova-T",
                "features": {
                    "keywords": [
                        "AbbVie",
                        "blunder",
                        "cancer drug",
                        "Rova-T",
                        "$5.8 billion"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals",
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}